Neridronic acid (INN; the anion is called neridronate) is a bisphosphonate.

In Italy it is used to treat osteogenesis imperfecta and Paget's disease of bone.

[1] A 2013 clinical trial suggests complex regional pain syndrome type 1 (CRPS) responds to treatment with intravenous neridronate.

This drug article relating to the musculoskeletal system is a stub.

You can help Wikipedia by expanding it.